Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease



Rating:

Share or cite this content

Citations should be made in the following way:
A. Amaral Ibiapina Parente (Rio De Janeiro (RJ), Brazil), R. Baroni Aurílio (Rio De Janeiro (RJ), Brazil), C. Couto Sant'Anna (Rio De Janeiro (RJ), Brazil), M. Bazhuni Pombo Sant'Anna (Rio De Janeiro (RJ), Brazil), A. Lineu Kriski (Rio De Janeiro (RJ), Brazil), T. Da Silva Santos Malaquias (Rio De Janeiro (RJ), Brazil), S. Ferreira (Rio De Janeiro (RJ), Brazil), C. Pereira (Rio De Janeiro (RJ), Brazil), L. De Melo Lima (Rio De Janeiro (RJ), Brazil), M. Alexandrino De Souza Pinheiro (Rio De Janeiro (RJ), Brazil), B. Marques Barreto (Rio De Janeiro (RJ), Brazil). Late Breaking Abstract - The use of Xpert Ultra in the diagnosis of tuberculosis in childhood and adolescence. 3096

Member's Comments

No comment yet.

Related content which might interest you: Modern characteristics of childhood tuberculosis Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Late Breaking Abstract - The tuberculosis diagnostic evaluation cascade of care at microscopy centers linked to Xpert MTB/RIF hubs in Uganda Source: International Congress 2017 – Update on TB: latest news Year: 2017 Late Breaking Abstract - Tackling the diagnostic challenge of COVID-19 – beyond a ‘false-negative’? Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Xpert MTB/RIF Ultra: the long-awaited game changer for tuberculous meningitis? Source: Eur Respir J, 50 (4) 1701201; 10.1183/13993003.01201-2017 Year: 2017 Late Breaking Abstract - A symptom-based algorithm to improve asthma diagnosis in early childhood:the CHILD Cohort Study Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019 Challenges in childhood tuberculosis Source: Eur Respir Monogr 2018; 82: 234-262 Year: 2018 Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Late Breaking Abstract - Therapeutic drug monitoring in a patient with very advanced XDR-TB Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis Year: 2021 Late Breaking Abstract - Frequency and characteristics of TB relapses Source: International Congress 2017 – Late-breaking studies in pulmonary diseases Year: 2017 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 MDR-TB: Early screening or future screaming Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Late Breaking Abstract - Validation of a clinical score predictive of SARS-CoV-2 infection in pneumonia inpatients Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Perinatal tuberculosis: A forgotten disease? Source: International Congress 2016 – Paediatric respiratory infections Year: 2016 Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Source: Eur Respir J 2016; 48: 516-525 Year: 2016 How do we diagnose tuberculosis in early childhood? Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Tuberculosis - Basics in diagnosis and treatment Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine Year: 2017 Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Late Breaking Abstract - Impact of the SARS-CoV-2 pandemic on incidence and phenotype of tuberculosis in a UK hotspot Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease Year: 2021